title: [Hirsutism and hypertrichosis in adults: investigations and treatment].
abstract: Hypertrichosis, characterized by increased hair growth located in non-androgen-dependent areas, does not justify the monitoring of hormone levels, conversely to hirsutism, with increased hair growth in androgen-dependent areas of the female genitals. Adult hypertrichosis is iatrogenic (minoxidil, ciclosporine, diazoxide or glucocorticosteroids), of metabolic origin (porphyria), nutritional (anorexia) or paraneoplastic (hypertrichosis lanuoginosa). Metabolic or general assessment can help clinical diagnosis. In non-iatrogenic hirsutism the following must be eliminated: 1) a virilizing tumor (ovarian, adrenal) when confronted with rapid progression or recent hirsutism, plasma testosterone (T)>1.5ng/ml and/or (adrenal tumor) DHEA-sulfate (DHEAS)>700 microgram/dl and associated with hypertension; 2) when confronted with characteristic signs of hirsutism, Cushing's syndrome (post-dexamethasone cortisol), hyperprolactinemia (pooled PRL), or acromegalia (IGF1). Measurement of 17-OH-progesterone at 8 am on the 4th day of the cycle detects the late manifestation homozygous forms of a 21-hydroxylase (21OHD) block. The more frequent forms are: 1) ovarian polymicrocystic or hirsutism-anovulation syndromes without other causes (LH/FSH, T, hyperinsulinemia, sonography); 2) functional adrenal hyperandrogenia (increased DHEAS without organic cause); 3) idiopathic hirsutism. Treatment can be local (discoloration, depilation, diathermo-coagulation, laser). Treatment of hirsutism of organic origin is etiologic. The inhibitory effects of glucocorticosteroids are mediated by 21OHD. The most effective treatments are anti-androgenic: cyproterone acetate, progesterone-like and anti-gonadotropic (contraceptive) agents; and the only product in France officially indicated in hirsutism , spironolactone (anti-mineralocorticosteroid); and flutamide, pure anti-androgen (probably hepatoxic). Finasteride (type II 5 alpha-reductase inhibitor) appears less effective. Estrogen-progestagen-like agents can be associated with anti-androgens. We should also mention the GnRH-agonists, and finally, dietetics and metformine (in cases of insulin-resistance).
authors.affiliation: Service d'Endocrinologie, Hôpital de Rangueil, CHU de Toulouse, 31403 Toulouse Cedex 4, France.
authors.forename: A
authors.initials: A
authors.lastname: Bennet
mesh_terms: D000328:Adult; D000726:Androgen Antagonists / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004700:Endocrine System Diseases / Q000150:complications; D004967:Estrogens / Q000627:therapeutic use; D005260:Female; D006628:Hirsutism / Q000175:diagnosis* / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D006983:Hypertrichosis / Q000175:diagnosis* / Q000503:physiopathology / Q000628:therapy*; D007049:Iatrogenic Disease; D008297:Male
chemical_list: D000726:Androgen Antagonists; D004967:Estrogens